Navigation Links
Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients With Known Diagnosis
Date:6/9/2008

NEWPORT NEWS, Va., June 9 /PRNewswire/ -- A group of surgeons from Legacy Good Samaritan Hospital (Portland, Oregon) have found Breast-Specific Gamma Imaging (BSGI) has a significant value in the pre-operative assessment for the extent of breast cancer in patients with known diagnosis. The findings were presented at The Society of Black Academic Surgeons Annual meeting held in Cleveland, Ohio.

BSGI is a molecular breast imaging technique used for the early detection of breast cancer and in the differentiation of malignant and benign tumors. It relies on advanced gamma imaging technology and mammographic positioning to optimize results. For this study BSGI was conducted with a commercially available high-resolution gamma camera, the Dilon 6800.

The study evaluated 138 patients with a cancer diagnosis. In this group, additional disease was found in a total of 11 percent of patients. Six percent were in the same breast and 5 percent were in the opposite breast. This finding is very similar to that of an MRI study conducted by Bilimoria from Northwestern University; however, BSGI provided a significantly lower false positive rate of 7 percent compared to 78 percent with the MRI study.

Member of the Legacy Good Samaritan Hospital group of surgeons, Dr. M. Zhou, concluded that BSGI parallels MRI in sensitivity in the preoperative setting, demonstrates better specificity than MRI, and is less expensive than MRI.

About Dilon Technologies

Dilon Technologies Inc. is bringing innovative new medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform BSGI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; Northwestern Memorial Hospital, Chicago; and The Rose, Houston. For more information on Dilon Technologies please visit http://www.dilon.com.

M. Zhou MD, N. Johnson MD, S. Gruner MD, G.W. Ecklund MD, P. Meunier MD, S. Bryn RN, G. Green MD. Clinical Utility of Breast Specific Gamma Imaging For Evaluating Disease Extent in the Newly Diagnosed Breast Cancer Patient. SBAS 18th Annual Scientific Session, Cleveland, OH, April 18, 2008.


'/>"/>
SOURCE Dilon Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Sports Legacy Institute Announces Findings of Forensic Examinations on Wrestler Chris Benoits Brain
2. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
3. Gilbert Hospital Continues Cutting Edge Treatments
4. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
5. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
6. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
7. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
8. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
9. Hospital to Hold MRSA Briefing for Media and Community Leaders
10. Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter
11. Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Cardiovascular Surgery Devices - Medical Devices Pipeline Assessment, ... report, "Cardiovascular Surgery Devices - Medical Devices Pipeline ... Devices currently in pipeline stage. ... comprehensive information on the pipeline products with comparative ... development. The report reviews major players involved in ...
(Date:2/8/2016)... 2016  Labvantage Lx, a newcomer to the ... sexual enhancement product, EnduramenT. Setting a new standard ... a patented biomedical breakthrough molecule that promotes the ... responsible for many biological functions including erectile function. ... Forgoing the use of prescription medications, scientists working ...
(Date:2/8/2016)... TOKYO and FAIRFIELD, N.J. ... (Otsuka) and Medimetriks Pharmaceuticals, Inc. (Medimetriks) today announced that ... exclusive development and commercialization rights for OPA-15406 in the ... agreement also provides manufacturing rights.  OPA-15406 is a topical, ... for atopic dermatitis. --> ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... 2016 , ... Stephanie Hebert Insurance Agency, serving families of ... charity campaign. As part of their ongoing community involvement program, funds are now ... children deserve a voice, and in the spirit of neighbors helping neighbors in ...
(Date:2/8/2016)... , ... February 08, 2016 , ... A man who has struggled to quit smoking, ... Laser Therapy , was determined to find solutions to his problems – and he did. ... Digest is ready to introduce his breakthrough inventions to the world and better people's ...
(Date:2/8/2016)... York, NY (PRWEB) , ... February 08, 2016 , ... ... are too much to handle, you are not alone. According to the Center for ... include heart disease, stroke, type 2 diabetes and certain types of cancer, some of ...
(Date:2/8/2016)... Hilton Head Island, SC (PRWEB) , ... February 08, 2016 , ... ... Head and surrounding areas with a vital new community enrichment program, has teamed up ... to local women and children suffering from intimate abuse. To support all those victimized ...
(Date:2/8/2016)... ... February 08, 2016 , ... Local ... the greater Venice, FL area, has initiated a fundraiser for a two year ... just four days after Christmas. To support this beautiful child who is facing ...
Breaking Medicine News(10 mins):